Belgium· BE-AMP-SAM663965-00
Welireg 40 mg
A belzutifan product containing belzutifan, registered in Belgium by Merck Sharp & Dohme. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Belzutifan is registered in 14 of 19 countries.
Countries holding a registration under ATC L01XX74 (belzutifan), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Belzutifan · ATC L01XX74
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of belzutifan costs, country by country.
Normalised to the WHO defined daily dose (0.12 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Belzutifan · price per daily dose (0.12 g)
USD · FX 28 Sept 2026
- FR France$0.54
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Belzutifan
- Manufacturer
- Merck Sharp & Dohme
- Country
- Belgium (BE)
- ATC code
- L01XX74
- ATC class
- Belzutifan
- Defined daily dose
- 0.12 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Belzutifan in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandWelireg 40 mg, FilmtablettenMSD Merck Sharp & Dohme AG
- United StatesWELIREGMerck Sharp & Dohme LLC
- SpainWELIREG 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMerck Sharp & Dohme B.V.
- FinlandWELIREGMerck Sharp & Dohme B.V.
- FranceWELIREG 40 mg, comprimé pelliculéMERCK SHARP & DOHME (PAYS-BAS)
- IrelandWELIREG 40 mg film-coated tabletsMerck Sharp & Dohme BV,
- IcelandWeliregMerck Sharp & Dohme B.V.*
- NetherlandsWELIREG 40 mg filmomhulde tablettenMerck Sharp & Dohme B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Welireg
- Liechtenstein · Welireg
- Norway · Welireg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/683bb160-3f56-47e8-915f-92ffd2a37bb4 GET /v1/drugs/683bb160-3f56-47e8-915f-92ffd2a37bb4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Welireg 40 mg",
"name_fr": "Welireg 40 mg",
"name_nl": "Welireg 40 mg",
"amp_code": "SAM663965-00",
"strengths": [
"40.0000",
"40.0000"
],
"pack_count": 2,
"substances": [
"Belzutifan",
"Mannitol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Belzutifan",
"authorisation_numbers": [
"EU/1/24/1893/002",
"EU/1/24/1893/001"
]
}See everything about belzutifan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.